Hindustan Unilever Limited has announced the grant of stock options to eligible employees under its Performance Share Plan Scheme 2024. The Nomination and Remuneration Committee approved the grant through a Circular Resolution dated March 15, 2026.

Stock Option Grant Details

The committee has approved the allocation of stock options to employees as part of the company's employee incentive program. The grant represents part of Hindustan Unilever's ongoing efforts to align employee interests with shareholder value creation.

Regulatory Compliance

The company has clarified that this grant of options under the HUL Performance Share Plan Scheme 2024 does not constitute a material event under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure has been made specifically for shareholder information and to ensure transparency in corporate governance.

Corporate Communication

The intimation was formally communicated to both BSE Limited and National Stock Exchange of India Limited on March 16, 2026. Company Secretary and Compliance Officer Radhika Shah signed the disclosure document, ensuring proper regulatory compliance and stakeholder communication.

Hindustan Unilever Limited has successfully completed the divestment of its entire 19.8% shareholding in Nutritionalab Private Limited for approximately ₹307 crore, according to a regulatory filing dated March 4, 2026. This strategic transaction represents a significant portfolio optimization move by the FMCG major.

Transaction Details

The company informed stock exchanges BSE and NSE about the completion of this divestment under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. This follows the initial announcement made on February 12, 2026, regarding the proposed sale of the shareholding.

Strategic Portfolio Optimization

This divestment aligns with Hindustan Unilever's broader strategy of focusing on core business operations while optimizing its investment portfolio. The transaction enables the company to reallocate capital more efficiently across its primary FMCG business segments and growth initiatives.

The successful completion of this sale demonstrates the company's ability to execute strategic transactions and realize substantial value from its investments. Such portfolio optimization moves are typically undertaken to enhance operational focus and improve capital allocation efficiency.

Financial Impact and Capital Deployment

The ₹307 crore proceeds from this divestment will provide Hindustan Unilever with enhanced financial flexibility. This capital can be deployed towards strengthening the company's core FMCG operations, funding growth initiatives, or other strategic priorities as determined by management.

The transaction represents a complete exit from the Nutritionalab investment, allowing the company to concentrate its resources on areas where it can achieve greater strategic alignment and operational synergies. The clean divestment underscores the company's commitment to optimizing its investment portfolio for enhanced returns and operational focus.